AD: SALVO – Oxford Vaccine Group

Help us investigate the first ever vaccine for Invasive Non-Typhoid Salmonella (iNTS) – The SALVO Trial

You are invited to take part in a study to investigate a new vaccine for invasive non-Typhoid Salmonella (iNTS) disease. The study is being run by the Oxford Vaccine Group which is part of the University of Oxford.

If you are aged 18 to 55 years old, in good health and live in the Oxford area, then you may be eligible to take part. We will provide reimbursement up to a maximum of £585, for your time, inconvenience and travel. The total study participation time is 12 months.

If you are interested in finding out more, please visit our website: where you can access the Participant Information Sheet and register your interest in joining the study.

In addition, if you would like any further information regarding the study please contact us on:

Email: [email protected]   Tel: 01865 611400